- UPDATE – Ikena Oncology Announces Strategic Update
- Ikena Oncology Announces Strategic Update
- Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
- Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
- Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
- Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
- Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
- Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
- Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results
- Ikena Oncology to Present at Multiple November 2023 Investor Conferences
More ▼
Key statistics
On Friday, Ikena Oncology Inc (IKNA:NMQ) closed at 1.77, 73.53% above the 52 week low of 1.02 set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.72 |
---|---|
High | 1.81 |
Low | 1.72 |
Bid | 1.75 |
Offer | 1.79 |
Previous close | 1.79 |
Average volume | 719.98k |
---|---|
Shares outstanding | 48.26m |
Free float | 45.33m |
P/E (TTM) | -- |
Market cap | 85.42m USD |
EPS (TTM) | -1.58 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼